Nu Skin Enterprises (NYSE:NUS) Upgraded to Buy at StockNews.com

Nu Skin Enterprises (NYSE:NUS) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Tuesday.

Separately, DA Davidson lowered their price objective on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th.

Nu Skin Enterprises Price Performance

Shares of NYSE NUS opened at $7.87 on Tuesday. The business’s 50 day moving average price is $6.91 and its 200 day moving average price is $7.28. The firm has a market cap of $391.32 million, a P/E ratio of -2.67 and a beta of 1.17. Nu Skin Enterprises has a 52 week low of $5.95 and a 52 week high of $14.04. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. The firm had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, sell-side analysts expect that Nu Skin Enterprises will post 1.05 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in NUS. Creative Planning lifted its position in shares of Nu Skin Enterprises by 43.0% during the 3rd quarter. Creative Planning now owns 41,226 shares of the company’s stock valued at $304,000 after buying an additional 12,398 shares in the last quarter. Ballentine Partners LLC purchased a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at approximately $133,000. Covestor Ltd lifted its position in shares of Nu Skin Enterprises by 110.9% during the 3rd quarter. Covestor Ltd now owns 10,140 shares of the company’s stock valued at $75,000 after buying an additional 5,333 shares in the last quarter. Versor Investments LP purchased a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at approximately $86,000. Finally, Aigen Investment Management LP purchased a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at approximately $111,000. Hedge funds and other institutional investors own 82.84% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.